Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation

Best Practice and Research: Clinical Haematology

Volumn 14, Issue 2, 2001, Pages 257-279

  Ruggeri, Zaverio M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adhesion; Aggregation; Haemostasis; Platelet; Thrombosis; von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; FIBRIN; MEMBRANE RECEPTOR; PLASMA PROTEIN; POLYMER; PROCOAGULANT; PROTEIN SUBUNIT; PROTEINASE; VON WILLEBRAND FACTOR;

ARTICLE; BINDING AFFINITY; BIOSYNTHESIS; BLOOD VESSEL INJURY; CELL SURFACE; COENZYME; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEMOSTASIS; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; STRUCTURE ANALYSIS; SUBENDOTHELIUM; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

EID: 0034919227     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.2001.0133     Document Type: Article

References (105)

1. Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease. With observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on anticoagulant against antihemophilic factor
2. von Willebrand disease
3. Variant von Willebrand's disease: Characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets
4. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit
5. Studies on factor VIII-related protein. II. Estimation of molecular size differences between factor VIII oligomers
6. Electron microscopy of von Willebrand factor
7. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor
8. Wall shear rate in arterioles in vivo: Least estimates from platelet velocity profiles
9. The complex multimeric composition of factor VIII/von Willebrand factor
10. Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers IID and IIE)
11. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor
12. Inducible secretion of large, biologically potent von Willebrand factor multimers
13. Multimeric structure of platelet factor VIII/von Willebrand factor. The presence of larger multimers and their reassociation with thrombin-stimulated platelets
14. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: Implications for pathophysiology and therapy of von Willebrand's disease subtypes
15. Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura
16. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis
17. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion
18. Deficient activity of von Willebrand factor - Cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura
19. Amino acid sequence of human von Willebrand factor
20. Identification of disulfide-bridged substructures within human von Willebrand factor
21. Localization of disulfide bonds in the cystine knot domain of human von Willebrand factor
22. Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes
23. Localization of factor VIII-procoagulant antigen: An immunohistological survey of the human body using monoclonal antibodies
24. Distribution of factor VIII mRNA and antigen in human liver and other tissues
25. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor
26. A monoclonal antibody to von Willebrand factor (VWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature VWF polypeptide
27. Fine mapping of monoclonal antibody epitopes on human von Willebrand factor using a recombinant peptide library
28. Expression of von Willebrand factor 'Normandy': An autosomal mutation that mimics hemophilia A
29. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease
30. Molecular characterization of a unique von Willebrand disease variant
31. Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease
32. Patient with type 2N von Willebrand disease is heterozygous for a new mutation: Gly22Glu. Demonstration of a defective expression of the second allele by the use of monoclonal antibodies
33. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
34. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets
35. Localization of binding sites within human von Willebrand factor for monomeric type III collagen
36. Isolation and characterization of a collagen binding domain in human von Willebrand factor
37. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen Types I and III
38. Interaction of the von Willebrand factor (VWF) with collagen
39. von Willebrand factor binds to native collagen VI primarily via its AI domain
40. Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flow
41. Localization on von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen
42. A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728
43. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein lb, heparin, and collagen, and characterization of its three distinct functional sites
44. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor
45. Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains
46. von Willebrand factor. A reduced and alkylated 52/48 kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib
47. Molecular analyses of the platelet glycoprotein Ib-IX-V receptor
48. cDNA sequences for human von Willebrand factor five reveal types of repeated domains and five possible protein sequence polymorphisms
49. Structure of the von Willebrand factor domain interacting with glycoprotein Ib
50. Dimeric ristocetin flocculates proteins, binds to platelets and mediates von Willebrand factor-dependent agglutination of platelets
51. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanisms of modulation of von Willebrand factor by ristocetin and botrocetin
52. Determination of the solution structure of a platelet-adhesion peptide of von Willebrand factor
53. Localization of von Willebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to-alanine scanning mutagenesis
54. Functional modulation of the isolated glycoprotein Ib-binding domain of von Willebrand factor expressed in Escherichia coli
55. Optimization of a recombinant von Willebrand factor fragment as an antagonist of the platelet glycoprotein Ib receptor
56. Conformational changes in the AI domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibα
57. Interaction of asialo von Willebrand factor with glycoprotein lb induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation
58. Role of botrocetin in platelet agglutination: Formation of an activated complex of botrocetin and von Willebrand factor
59. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin: A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib
60. Crystal structure of the A3 domain of human von Willebrand factor: Implications for collagen binding
61. The von Willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif
62. Crystal structure of von Willebrand factor AI domain in complex with the function blocking NMC-4 Fab
63. Crystal structure of the A domain from the α subunit of integrin CR3 (CDIIb/CDI8)
64. 2) integrin
65. 1
66. 1 (VLA-2, CD49b/CD29)
67. 1. Critical role of conserved residues in the metal ion-dependent adhesion site (MIDAS) region
68. Modeling and functional analysis of the interaction between von Willebrand factor AI domain and glycoprotein Ibα
69. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
70. New perspectives in cell adhesion: RGD and integrins
71. Integrins: A family of cell surface receptors
72. Integrins: Versatility, modulation and signaling in cell adhesion
73. Evidence that three adhesive proteins interact with a common recognition site on activated platelets
74. Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to GP IIb-IIIa without interacting with other adhesive molecules: Selectivity is conferred by Pro 1743 and residues adjacent to the sequence Arg 1744-Gly1745-Asp1746
75. Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis
76. Endothelial-cell-specific regulation of von Willebrand factor gene expression
77. von Willebrand factor promotes endothelial cell adhesion via an arg-gly-asp-dependent mechanism
78. von Willebrand factor binds specifically to sulfated glycolipids
79. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673
80. Covalent crosslinking of von Willebrand Factor to fibrin
81. Multimer size dependence of von Willebrand factor binding to crosslinked or noncrosslinked fibrin
82. Analysis of pulsatile viscous blood flow through diseased coronary arteries of man
83. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi
84. The effect of flow and mass transport in thrombogenesis
85. Rheological aspects of thrombosis and haemostasis: Basic principles and applications
86. Conditions for the occurrence of large near-wall excesses of small particles during blood flow
87. Rheology of thrombosis
88. Role of von Willebrand factor associated to extracellular matrices in platelet adhesion
89. Subendothelial proteins and platelet adhesion
90. Functional behavior of vessels from pigs with von Willebrand disease
91. Initiation of platelet adhesion by arrest onto fibrionogen or translocation on von Willebrand factor
92. Modulation of von Willebrand factor conformation and adhesive function by an internalized water molecule
93. 546 → Val) associated with an unusual phenotype
94. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease
95. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow
96. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood
97. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine
98. Adenosine diphosphate induces binding of von Willebrand factor to human platelets
99. von Willebrand factor interaction with the glycoprotein IIb/IIIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia
100. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen
101. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets
102. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions
103. Classification of von Willebrand disease
104. von Willebrand factor
105. Old concepts and new developments in the study of platelet aggregation